Technologic advances enable performance of diffusion-weighted imaging (DWI) at ultrahigh b-values, where standard monoexponential model analysis may not apply. Rather, non-Gaussian water diffusion properties emerge, which in cellular tissues are, in part, influenced by the intracellular environment that is not well evaluated by conventional DWI. The novel technique, diffusion kurtosis imaging (DKI), enables characterization of non-Gaussian water diffusion behavior. More advanced mathematical curve fitting of the signal intensity decay curve using the DKI model provides an additional parameter K app that presumably reflects heterogeneity and irregularity of cellular microstructure, as well as the amount of interfaces within cellular tissues. Although largely applied for neural applications over the past decade, a small number of studies have recently explored DKI outside the brain. The most investigated organ is the prostate, with preliminary studies suggesting improved tumor detection and grading using DKI. Although still largely in the research phase, DKI is being explored in wider clinical settings. When assessing extracranial applications of DKI, careful attention to details with which body radiologists may currently be unfamiliar is important to ensure reliable results. Accordingly, a robust understanding of DKI is necessary for radiologists to better understand the meaning of DKI-derived metrics in the context of different tumors and how these metrics vary between tumor types and in response to treatment. In this review, we outline DKI principles, propose biostructural basis for observations, provide a comparison with standard monoexponential fitting and the apparent diffusion coefficient, report on extracranial clinical investigations to date, and recommend technical considerations for implementation in body imaging.
D
iffusion-Weighted Imaging (DWI) has become established as a powerful magnetic resonance imaging (MRI) technique for evaluating pathology throughout the body and is now routinely incorporated into many body MRI protocols, mainly in oncology. 1, 2 DWI is performed by serially imaging the same tissue while varying the degree of water diffusion sensitization. The imaging gradient strength, direction, and temporal profile affect sensitivity to diffusion and are commonly reduced to a single simplified parameter referred to as the b-value [unit: s/mm 2 ]. The images obtained at different b-values are subsequently used for computing a parametric map that allows quantitative assessment of the tissue's water diffusion behavior. In clinical body imaging, DWI is typically performed using b-values up to 800-1000 s/mm 2 , and subsequent quantification is typically performed using a monoexponential fit. 3 For simplicity, this model assumes Gaussian (free) diffusion behavior, in which free tissue diffusion would yield a normal distribution of tissue diffusivities. This Gaussian diffusion behavior would result in linear decay of the natural logarithm of the DWI signal intensity (SI) as the b-value increases, the slope of which is referred to as the apparent /s) to emphasize that it is not the real diffusion coefficient. 3 ADC is derived from the equation:
S i 5S 0 Ã e ð2b i ÃADC Þ , in which S i is the SI at b-value b i , and S 0 represents the estimated SI at a b-value of 0 in the absence of any noise contribution.
Historically, MRI scanners were limited in their abilities to obtain images at b-values greater than 1000 s/mm 2 due to insufficient signal-to-noise ratio (SNR) and increased anatomic distortions resulting from field inhomogeneity and induced eddy currents. However, improvements in hardware and software within modern MRI systems now enable the acquisition of ultrahigh b-value images (>1000 s/mm 2 ), which when acquired with good image SNR have been shown to enhance clinical disease assessment for prostate cancer detection and glioma characterization. 4, 5 Acquiring DWI at ultrahigh b-values often reveals the presence of non-Gaussian diffusion effects, thus requiring a more sophisticated model for analysis. One such model is termed diffusion kurtosis imaging (DKI), which potentially provides more information on tissue structure than does standard monoexponential analysis for b-values less than 1000 s/ mm 2 . DKI was first described by studies in 2004 6 and 2005 7 and initially was applied exclusively for brain imaging. 5, 8, 9 However, in recent years studies have shown the feasibility of applying DKI at multiple extracranial sites. [10] [11] [12] [13] Therefore, body radiologists may benefit through a better understanding of the major concepts of DKI. In this article, we review the basic principles of DKI, proposed biologic correlates, technical considerations to facilitate clinical translation, and potential applications outside the brain reported within the recent peer-reviewed literature.
DKI: Underlying Model
Past studies have reported on the potential value of DWI using b-values over 1000 s/mm 2 in oncologic applications, almost all showing improved tumor conspicuity against a fading background signal intensity on the ultrahigh b-values images. [14] [15] [16] However, these studies have commonly postprocessed the image sets using a standard monoexponential fit to obtain ADC maps. [17] [18] [19] While this approach may appear straightforward, there is an assumption of monoexponential behavior of water diffusivity. The monoexponential model, which applies a linear fit to the natural logarithm of the SI, is reasonable at b-values up to $600-1000 s/mm 2 , depending on the given tissue. However, as the b-value increases, the logarithmic SI decay plot no longer maintains a linear shape, but rather exhibits a distinct curvature with a positive deviation from the plot of the monoexponential model 7 ( Fig. 1 ). This curvature indicates the presence of water diffusion behaviors away from Gaussian predictions, and accordingly, that alternate models should be applied when observed. 7 DKI analyses non-Gaussian water diffusivity using a polynomial model according to the following equation: /s) that is corrected to account for the observed non-Gaussian behavior. For histogram descriptions, a distribution with greater kurtosis has a more peaked distribution in comparison with a normal distribution (Fig.  2) . Accordingly, K app reflects the more peaked distribution of tissue diffusivities that occurs in the setting of nonGaussian diffusion behavior. K app is determined by the SI decay curvature away from the plot that would be predicted by a monoexponential fit, 7 whereas D app is determined by the slope of the SI decay plot as b approaches 0. Not only does the DKI model potentially better reflect water diffusivity in tissues at ultrahigh b-values, it also provides an additional parameter K app that contains specific information on the non-Gaussian diffusion behavior. Thus, the DKI model provides radiologists with an opportunity to potentially gain further insights into tissue characteristics than are obtained through standard DWI. Other models for fitting extended diffusion data are described, including the biexponential model that separates the water diffusivity into two components (fast and slow, with their respective relative volumes and diffusivities), as well as the stretchedexponential model that views water diffusion as comprising multiple Gaussian compartments with a wide distribution of diffusivities. 20, 21 However, given the noise inherent in clinical datasets, the DKI model is potentially the most robust, as it has only two unknown parameters (D app and K app ) that need to be estimated when S 0 is known or can be derived.
3,12
Biostructural Basis K app is a phenomenological parameter, 22 supported by observations of it providing excellent mathematical fitting of the SI decay plot at very high b-values (although lower than 2500-3000 s/mm 2 ). 3 It has no direct biophysical basis and in this sense it is similar to ADC, which also represents an "apparent" parameter that has only indirect biophysical correlates. Nonetheless, the underlying basis of DKI metrics have been hypothesized. 3 Tissue ADC measurements at bvalues less than 1000 s/mm 2 have been ascribed as a measure largely of the extracellular space, 3, 22 reflecting the extent to which water molecules are hindered outside of cells and so are influenced by tissue architectural properties that include vessels, ducts, and extracellular space tortuosity. Thus, cellular arrangements, cell size distributions, cellular density, extracellular space viscosity, glandular structures, and integrity of membranes all have the potential to modulate extracellular space water motion. Accordingly, reduced ADC has often been attributed to increasing cellular density, given the effect of hydrophobic cell membranes in limiting extracellular water motion. 3 However, the degree of water hindrance scaling with respect to cellularity is dependent on a uniform distribution of cell sizes, and the inverse relationship between cellularity and ADC does not apply to all tissues. For example, in bone marrow the presence of smaller sized hematopoietic cells intermixed with larger fat cells initially increases ADC with increasing cellularity. 23, 24 Radiologists should also note that ADC correlates are not specific for the effects of cellularity on water motion, which can also be hindered simply by the presence of a greater concentration of macromolecules and increased viscosity. 7 In comparison, K app of tissues has been hypothesized at least in part to represent the direct interaction of water molecules with cell membranes and intracellular compounds, 3, 7, 22 although is also influenced by other extracellular factors that are difficult to separate. Le Bihan 25 suggests that water is not a homogeneous substance at the nanoscopic level, given the polar nature of the water molecule, which results in the formation of network clusters with differing degrees of hydrogen bonding and tetrahedrality. Furthermore, liquid water may form 3D arrays in the presence of interfaces with charged materials such as polarized cell or organelle membranes or protein molecules. Extensive selfassociations of water within charged environments result in organization of water molecules into layers with reduced diffusivity. In cells, proteins have an especially profound effect on water, given their presence of a charge that results in protein-water adsorption. These factors, taken together, may result in the marked hindrance of water motion, contributing to non-Gaussian diffusion observations. Increased kurtosis is suggested to occur in the setting of more irregular and heterogeneous environments with many or large interfaces, 7, 26 including the increased nuclear-cytoplasmic ratio of tumor cells. Kurtosis measurements potentially have greater specificity to reveal water interactions within cell and tissue components. 7 A prior study using a synthetic tumor cell environment that observed diffusion signal intensities to be sensitive to intracellular architecture but not to overall cell density supports the relationship between ultrahigh b-value DWI and intracellular water behavior. 27 Studies that observed associations between DKI metrics and microstructural properties of prostate cancer support this framework as well. 28, 29 Nonetheless, work remains to be done to fully understand the mechanisms underlying non-Gaussian diffusion, including other noncell-based influences and the precise biostructural significance of K app .
Acquisition and Postprocessing Considerations
In this section, we provide technical recommendations to guide body radiologists in implementing DKI in routine clinical practice. Table 1 provides general considerations, while Table 2 provides the specific acquisition parameters for a representative sample protocol for performing DKI of the prostate.
Image Acquisition DKI is acquired using a standard DWI sequence available on current-generation scanners, albeit incorporating ultrahigh b-values. Whereas standard DWI requires acquisition of only two b-values for the calculation of ADC, DKI requires acquisition of at least three distinct b-values given an additional unknown variable (K app ) within the formula. 3 In practice, we suggest acquiring more than three b-values, including at least two b-values both above and below 1000 s/mm 2 , to facilitate the successful capture of the non-Gaussian behavior. If the maximal b-value is not high enough, then the deviation of the curvature of the SI decay plot away from Gaussian will not be captured, and the ability of the sequence to measure non-Gaussian diffusion behavior decreases substantially. 33 In the brain, DKI is per- This more advanced technique has greater hardware, acquisition time, and postprocessing requirements and is beyond the scope of this article. 7, 26 Compared with the brain, tissues in the body generally exhibit faster signal decays at increasing b-values, as well as faster T 2 decays. 36 Moreover, larger-sized torso coils have less ideal receptivity and geometry in comparison with head coils. Therefore, the optimal choice of maximal b-value for DKI in body applications is lower than in the brain. Indeed, non-Gaussian behavior of the SI decay plot can be successfully captured at a maximal b-value of $1500-2000 s/mm 2 in body imaging. 11, 37, 38 On this basis, we suggest that a maximal b-value in this range may be appropriate for DKI body applications. Selection of the minimal b-value for DKI should take into account sensitivity to intravoxel incoherent motion (IVIM) effects that are visible at very low b-values (typically lower than 400 s/mm 2 ). These b-values are theoretically far from the high b-values used for DKI, such that the acquisition of multiple, very low b-value images, although standard for IVIM assessment, is, in principle, not needed when performing DKI. 39 While a minimal b-value of 0 is acceptable, In order for the calculated DKI metrics to be accurate, it is critical for the high b-value images to exhibit sufficient SNR. 34 Otherwise, the SI decay plot approaches the "noise floor," which in turn leads to an artifactual curvature of the SI decay plot and yields biased estimates of K app . 12, 41 The rate at which signal approaches the noise floor depends on diffusion properties of the tissue itself. That is, it is conceivable to have adequate SNR for K app estimation in one region (eg, high-grade prostate tumor) and inadequate SNR, leading to biased K app estimation in adjacent tissue (eg, normal prostate parenchyma). Consistently obtaining sufficient SNR at high b-values is particularly challenging in body imaging, given not only faster signal decays, but also the tendency to use faster acquisitions to compensate for respiration and other sources of motion. Therefore, it may be necessary to reduce the spatial resolution or increase the number of signal averages to maintain SNR. When allocating the number of averages, fewer averages may be required for the lower b-values, thereby enabling more averages to be allocated to the high b-value images, thus increasing their SNR. Given the pronounced SNR demands of DKI, optimized sequence parameters are likely to be different from that of conventional DWI in the same tissue.
As breath-hold imaging is associated with significantly reduced SNR for DWI, 42 either respiratory-triggered or free-breathing acquisitions are needed. Using the minimal possible echo time also helps raise SNR, which is facilitated at ultrahigh b-values through high-performance gradient systems. Use of a 3T system, when available, substantially improves SNR as well. Even with these considerations, SNR may still be insufficient. Post-hoc corrections of "noise floor" effects in the signal remain challenging, although some simple techniques have been proposed for clinical practice. 12, 41 Such techniques show an improved reliability of DKI measurements and may be an important step towards achieving routine clinical applicability of DKI in the body. 12 When incorporating noise compensation, an SNR of at least 2 on the high b-value images has been suggested as a minimum threshold for allowing for a reasonable estimate of K app . 41 However, even higher SNR is preferred, to the extent achievable. As already noted, DKI requires a minimum of only three b-values. In fact, it may be advantageous to avoid acquiring an excessive number of b-values. 26 A very large number of b-values increases the overall scan time, both increasing the likelihood of motion artifact and hindering incorporation of DKI into clinical protocols. On the other hand, a limited number of b-values in both high (500-1000) and ultrahigh (1500-2000) b-value ranges may be useful for successfully capturing the monoexponential and non-Gaussian components, respectively, of the SI decay curve. Therefore, the optimal number of b-values to obtain, as well as their distribution across the acquired range of bvalues, cannot be strictly prescribed and will depend on the clinical application, desire to obtain simultaneous IVIM and/or ADC estimates, expected SNR, likelihood of motion artifacts, scanner capability, and available imaging time. Some studies report performing kurtosis assessment of the full multidirectional diffusion tensor, described as diffusion kurtosis tensor imaging (DKTI). 43, 44 This approach acquires diffusion images in at least 15 different directions in order to assess the anisotropic directionality of diffusion and kurtosis behavior. 7 Similar to the above consideration of the number of b-values, acquisition of this many directions is not necessary for oncologic DKI. Rather, DKI can be performed based on a directionless "trace" of the diffusion tensor, which requires acquisition of only three directions. 7 Given the prohibitive scan time of the 15 directions needed to perform DKTI, DKI of the body has been performed overwhelmingly in a directionless fashion. This scheme highlights that DKI does not require tissue anisotropy and indeed provides markedly distinct information compared with DTI-derived metrics such as fractional anisotropy. 7 Finally, although not a parameter routinely manipulated by radiologists, the diffusion time, DT, indicating the time between onset of the two lobes of the diffusionencoding gradient, also impacts kurtosis estimates, given the greater physical diffusion distances probed with increasing DT. A short DT is advised in order to be sensitive to obstacles to non-Gaussian water diffusion that occur at short length scales and that influence K app , as well as to mitigate water exchange between tissue compartments that occurs at longer DT. 40 K app increases as DT increases from a short DT, reaching a peak value at an intermediate DT, and subsequently decreases with further increases in DT, ultimately approaching zero. 26, 40 In comparison, D app is relatively less sensitive to DT length. 40 Shorter DT may be achieved by minimizing TE times, which is facilitated through use of monopolar diffusion-encoding schemes 45, 46 and stronger gradient rise times.
Image Postprocessing
While DKI is acquired using standard DWI sequences, current clinical MR systems do not routinely provide in-line DKI postprocessing options. Therefore, separate postprocessing software is needed, which is becoming increasingly available. As a minimum, DKI analysis should provide at least two parametric maps corresponding to D app and K app , while b 0 and user-defined computed b-value images can also be generated. D app is analogous to the metric ADC that is familiar to radiologists, being reduced in the setting of impeded diffusion. While numerous factors influence these metrics, D app is presumed to be the more accurate measure of tissue diffusion, given its correction for non-Gaussian diffusion behavior. K app (unitless) equals 0 in the setting of completely Gaussian diffusion. 34 Biologic tissues tend to exhibit K app values between 0 and 1. 26 K app values greater than 1 indicate increased contributions attributable to kurtosis behavior. 7, 33 Studies also suggest lowering of K in the setting of posttreatment tumor necrosis. 33, 47 Postprocessing software commonly applies a maximal possible upper limit for K app , above which the value is likely to represent an outlier due to motion, noise, or other artifact. 26 While K app theoretically may be negative, it will measure at least 0 in the setting of water exchange between multiple compartments, as is generally the case within biologic tissues, 7, 26 and 0 can therefore be used as a minimal value for K app in curvefitting procedures. Reductions in D app are commonly, although not always, associated with elevations in K app . 10, 33, 34 As a result, the K app parametric map may visually appear analogous to an inverted version of the D app parametric map, both indicating abnormal diffusion behavior in similar anatomic locations. Therefore, a simple visual assessment of the two maps may be diagnostically insufficient. Rather, quantitative analysis incorporating direct measurements of D app and K app values is recommended in order to fully harness the complementary role of kurtosis in distinguishing tissue pathology (Figs. 3, 4) . In some circumstances, such as viscous or turbid fluid, reduced D app may be encountered, without elevated K app (Fig. 5 ).
Pitfalls
First, it is suggested to avoid using a monoexponential fit for DWI acquisitions that include ultrahigh b-values over 1000 s/ mm 2 . For such acquisitions, the monoexponential model no longer applies, and the obtained estimates of ADC will be less meaningful and potentially incorrect. In this context, it may be desired to both compute ADC maps with b-values less than 1000 s/mm 2 , as well as have very high b-value signal intensity images available for interpretation. 48 In this circumstance, the acquired ultrahigh b-value images should be excluded from the ADC map computation. Alternatively, two separate diffusion acquisitions may be performed altogether, one using b-values up to 1000 s/mm 2 and one using ultrahigh b-values, each optimized to achieve the maximal SNR possible for the b-value range used.
Likewise, the DKI model should not be applied when only b-values <1000 s/mm 2 are acquired. 33, 36, 44, 49, 50 Although software can mathematically fit the DKI equation using any range of b-values and output D app and K app parametric maps, there is no logical basis for doing so. Given the inclusion of an additional unknown variable in the DKI model, such postprocessing will provide a mathematically better goodness-of-fit to the raw data than a monoexponential model within the same b-value range. 34 However, this improved goodness-of-fit should not be viewed as evidence of appropriateness, as the non-Gaussian diffusion behavior that underlies the DKI fit has minimal effect for b-values within this range. Since the curvature occurring at very high b-values is not present within this range, values of D app will tend to approach those of ADC. 22, 34 On this basis, radiologists should not characterize DKI fitting performed within only a standard b-value range as either representing or supporting the presence of non-Gaussian water behavior. Likewise, biomedical journals should require the appropriate use of higher b-values in studies that aim to explore the clinical utility of DKI. Finally, when comparing goodness-of-fit between different diffusion models, it is important to apply corrections to account for the different number of model parameters. 13 Third, the DKI model fits the diffusion signal decay well only when b-values do not exceed 2500-3000 s/mm 2 depending on D app values. At higher b-values, the model, which is mathematical rather than physical, starts to fail, predicting increasing signal intensity as the b-value increases further, which is a physical non-sense. The b-value regime that we suggest for body applications of DKI is consistent with this upper limit.
Finally, as previously noted, radiologists need to ensure sufficient SNR on the high b-value images. This requirement represents an important barrier to widespread clinical application of DKI in body imaging at the present time. DKI postprocessing can technically be applied to SNR-poor image sets and yield D app and K app parametric maps from which mean values can be extracted. However, if the SNR is insufficient, then such data are prone to be heavily influenced by the image noise and thus may be spurious in nature. Therefore, the radiologist must always be aware of SNR issues during data acquisition and postprocessing, and implement adjustments appropriately. One method of improving the accuracy of parameter estimates is to use averaged signal intensity values over a user-defined ROI as inputs to model fitting (as opposed to individual voxel fitting), which also enables confidence intervals of parameters estimates to be obtained, if required.
Clinical Review
In this section we summarize applications of DKI outside the brain that have been reported within the peer-reviewed literature (Table 3 ).
Prostate
A number of studies have evaluated the use of ultrahigh bvalue images in detection and characterization of prostate cancer. 4, 18, 19, 51 Indeed, the use of ultrahigh b-values for prostate cancer detection are incorporated into the PI-RADS v. 2.0 guidelines, 48 that state that ultrahigh b-value images should be routinely acquired and inspected for focal areas of hyperintensity, although such areas must also be secondarily evaluated on the ADC map (obtained with bvalues 1000 s/mm 2 ), dynamic contrast-enhanced MRI, and T 2 -weighted imaging. These recommendations are corroborated in part from quantitative DKI studies conducted in the prostate, with at least 13 studies as of this writing measuring K app in benign or malignant prostate tissue, 10, 20, 21, 29, 37, 44, [52] [53] [54] [55] [56] [57] [58] although not all used a b-value over 1000 s/mm 2 . 44, 52 DKI has shown incremental improvements compared with standard DWI for differentiating benign and malignant prostate tissue, 37, 54, 55 as well as low and high grade tumors. 10 However, not all studies have confirmed a significant diagnostic improvement in tumor grade differentiation using DKI. 21, 57 A number of investigations report improved diagnostic performance of DWI for prostate cancer detection when using b-values greater than 1000 s/mm 2 . 4, 14, 30 While this improvement may relate to greater suppression of background benign tissue and thus higher lesion-to-background contrast at higher b-values, this effect only partly accounts 
Head and Neck
Three studies performed DKI using a b-value of $1500 s/ mm 2 for head and neck cancers, 11, 59, 60 showing improved goodness-of-fit using DKI as well as generation of nonredundant information. An additional study using a b-value of 1500 s/mm2 in patients undergoing neoadjuvant chemotherapy for nasopharyngeal carcinoma suggested DKI to be superior to standard monoexponential DWI for predicting early treatment response. 61 
Breast
Three studies have applied DKI using a maximal b-value of 2000-3000 s/mm 2 for assessment of breast diseases, 12, 62, 63 demonstrating non-Gaussian diffusion behavior. Two of these studies reported strong performance of both D app and K app for differentiating benign and malignant breast tissue, although with conflicting results in terms of which of these was the better-performing metric. 12, 63 The remaining study reported that fibroadenomas and fibrocystic change showed alterations only in K app .
62
Lung One study performed DKI of the lungs using hyperpolarized helium in a patient with small airway disease, showing an alteration in kurtosis, although not in ADC. 64 Another study showed a significant correlation between K app and the standardized uptake value of nonsmall-cell lung cancer imaged by hybrid 18 F -FDG PET/MRI. 65 
Kidney
Two studies have attempted DKI of normal renal tissue, although using a maximal b-value of 600 or 1000 s/ mm 2 . 49, 50 Interestingly, one of these studies reported higher K app in the renal medulla, whereas the other reported higher K app in the cortex. 49, 50 Nonetheless, the maximal b-values used in these studies are too low to support conclusions regarding the feasibility or utility of DKI in the kidneys.
Liver
One study explored DKI using a maximal b-value of 2000 s/ mm 2 in hypervascular hepatocellular carcinoma (HCC), reporting higher performance of K app than ADC for assessing posttreatment viability. 47 In addition, in an ex vivo study of a murine liver specimens with known fibrosis, DKI exhibited better goodness-of-fit than a monoexponential model. 13 Also, in an ex vivo study of HCC within human liver explants K app was positively correlated with tumor cellularity and reduced K app was observed in necrotic treated lesions. 33 Other Additional preliminary studies have demonstrated the feasibility of DKI within bladder (showing higher area under the curve of K app than ADC for differentiating low-and highgrade cancer), 38 human calf muscle in vivo, 66 rat myocardium ex vivo, 67 and human esophageal carcinoma ex vivo. 68 Another study demonstrated the feasibility of performing whole-body DKI processing in healthy human volunteers, although using a maximal b-value of 800 s/mm 2 . 36 At this b-value, values of D app will tend to approach those of ADC, and radiologists should not characterize non-Gaussian fitting performed within this standard b-value range as either representing or supporting DKI.
Future Directions
The potential of quantitative DKI, incorporating not just visual assessment of ultrahigh b-value images but also measuring K app , remains to be fully explored. Therefore, for initial validation studies examining the role of ultrahigh b-value DWI, radiologists are advised to include a quantitative DKI evaluation if possible. In particular, we suggest that DKI be explored during drug development to potentially establish K app and D app as pharmacodynamic biomarkers for treatments that would be expected to lead to decreased cellular complexity with treatment response, thereby leading to loss of kurtosis and increased diffusivity. 33 In this context, the potential of K app to serve as an independent measure of response beyond ADC can be explored. 23, 69 Also, quantitative DKI could become part of multiparametric imaging assessments, for instance to support radiomics development, to improve biologic understanding of tissue or tumor heterogeneity at multiple scales, to integrate with other existing biomarkers, and to support emerging clinical applications such as radiotherapy planning on the basis of quantitative tissue characteristics. 70 Ultimately, to establish DKI metrics as potential biomarkers a robust and rigorous biomarker development pathway is required, including establishment of quality control, measurement repeatability/reproducibility, understanding of sources of measurement error, evaluation of test-retest and interplatform repeatability, comparison of DKI metrics with ADC in multicenter studies, and validation of changes in DKI metrics using histopathology, molecular pathology, and other laboratory biomarkers in preclinical and clinical settings.
In conclusion, in comparison to the role of standard DWI and ADC in assessing extracellular water diffusion, DKI probes non-Gaussian interactions of water molecules within tissue environments and, through more advanced mathematical curve fitting, provides an additional parameter, K app , that presumably reflects the heterogeneity and irregularity of cellular microstructure, as well as the amount of interfaces within cellular tissues. Nonetheless, careful attention to detail with which body radiologists may not be currently familiar is important to ensure reliable results. While DKI is acquired using a standard DWI sequence, although incorporating ultrahigh b-values in order to detect the non-Gaussian behavior, additional dedicated postprocessing software is required for analysis and generation of DKI parametric maps. In this article we have suggested a maximal b-value of 1500-2000 s/mm 2 for DKI applications in the body, lower than typically used in the brain. In recent years, a small number of studies have explored the role of DKI outside the brain. The most investigated organ is the prostate gland, with preliminary studies suggesting potentially improved tumor detection and grading using DKI. Currently, DKI is still largely a research tool, and few compelling data support its routine use over conventional DWI measurements in oncologic assessments. Nonetheless, the technique is at a stage in which it can be explored in wider clinical settings. A robust understanding of DKI is important for radiologists to better understand what K app and D app mean in the context of different tumors and how these metrics vary between tumor types and in response to treatment. We therefore encourage body radiologists to employ DKI using the suggestions presented in this review, especially in the framework of future investigations of ultrahigh b-value imaging. Such efforts will enhance our knowledge of DKI findings and help better define the benefits and drawbacks of this novel technique.
